| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Academic drug discovery: Challenges and opportunities
|
Murray, Angela J.
|
|
|
29 |
4 |
p.
|
artikel
|
| 2 |
A call to rethink the necessity of and challenges facing academic research organizations in the new era of drug innovation in China
|
Huang, Huiyao
|
|
|
29 |
4 |
p.
|
artikel
|
| 3 |
A drug delivery strategy emerges that has the potential to transform cancer therapy
|
Theobald, Nigel
|
|
|
29 |
4 |
p.
|
artikel
|
| 4 |
Augmenting DMTA using predictive AI modelling at AstraZeneca
|
Ghiandoni, Gian Marco
|
|
|
29 |
4 |
p.
|
artikel
|
| 5 |
Context is everything in regulatory application of large language models (LLMs)
|
Tong, Weida
|
|
|
29 |
4 |
p.
|
artikel
|
| 6 |
Dual-target inhibitors of cholinesterase and GSK-3β to modulate Alzheimer’s disease
|
He, Junqiu
|
|
|
29 |
4 |
p.
|
artikel
|
| 7 |
Exploring the chemical space of orally bioavailable PROTACs
|
Apprato, Giulia
|
|
|
29 |
4 |
p.
|
artikel
|
| 8 |
Ferroptosis as a potential therapeutic target for age-related macular degeneration
|
Liu, Dongcheng
|
|
|
29 |
4 |
p.
|
artikel
|
| 9 |
Generation of a drug-induced renal injury list to facilitate the development of new approach methodologies for nephrotoxicity
|
Connor, Skylar
|
|
|
29 |
4 |
p.
|
artikel
|
| 10 |
Is calcitonin gene-related peptide (CGRP) the missing link in food histamine-induced migraine? A review of functional gut-to-trigeminovascular system connections
|
de Mora, Fernando
|
|
|
29 |
4 |
p.
|
artikel
|
| 11 |
Making more of less: using divestitures to unlock pharmaceutical innovation
|
McCarthy, Killian J.
|
|
|
29 |
4 |
p.
|
artikel
|
| 12 |
Microfluidics for personalized drug delivery
|
Alavi, Seyed Ebrahim
|
|
|
29 |
4 |
p.
|
artikel
|
| 13 |
New approaches for challenging therapeutic targets
|
Sharma, Karlie R.
|
|
|
29 |
4 |
p.
|
artikel
|
| 14 |
Orphan GPR52 as an emerging neurotherapeutic target
|
Ali, Saghir
|
|
|
29 |
4 |
p.
|
artikel
|
| 15 |
Potential of postbiotics for the treatment of metabolic disorders
|
Mishra, Neeraj
|
|
|
29 |
4 |
p.
|
artikel
|
| 16 |
Recent advances in 3D bioprinting for cancer research: From precision models to personalized therapies
|
Ruchika,
|
|
|
29 |
4 |
p.
|
artikel
|
| 17 |
Recent trends in targeted delivery of smart nanocarrier-based microbial enzymes for therapeutic applications
|
Jangra, Nikita
|
|
|
29 |
4 |
p.
|
artikel
|
| 18 |
Rise of the Allotrope Simple Model: Update from 2023 Fall Allotrope Connect
|
Gardiner, Spencer
|
|
|
29 |
4 |
p.
|
artikel
|
| 19 |
Transfer learning empowers accurate pharmacokinetics prediction of small samples
|
Guo, Wenbo
|
|
|
29 |
4 |
p.
|
artikel
|
| 20 |
Transitioning biomedical research toward human-centric methodologies: systems-based strategies
|
Constantino, Helder
|
|
|
29 |
4 |
p.
|
artikel
|
| 21 |
Treating liver cancer through arginine depletion
|
Prasad, Yenisetti Rajendra
|
|
|
29 |
4 |
p.
|
artikel
|
| 22 |
Unveiling the impacts of FDA Breakthrough Therapy Designation: a dual-perspective examination of economic and developmental outcomes for biotechnology companies
|
Williamson, Joab
|
|
|
29 |
4 |
p.
|
artikel
|
Tijdschrift beschrijving